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Objectives
This study aimed to explore the experiences of people
participating in a clinical trial in Tanzania. We sought
to understand the meaning attached to participation and
how experiences of being in the trial related to partici-
pants’ original motivations for consenting, in order to
explore appropriate strategies for recruitment in a devel-
oping country setting.
Methods
We designed a qualitative study alongside a clinical
observational trial of the efficacy and safety of artemisi-
nin-based combination therapy (ACT) for malaria in
patients concomitantly receiving antiretroviral therapy
(ART) for HIV in Muheza, Tanzania. Focus-group dis-
cussions have been held with HIV-positive and HIV-
negative people who have participated in the trial, and
with HIV-positive people who were screened but who
did not participate. This data has been triangulated with
in-depth interviews with staff conducting the trial and
delivering HIV care at the hospital where the trial was
conducted. Data is being analysed using an iterative,
line-by-line approach based on the principles of
grounded theory, to identify units of meaning and
develop themes and constructs from the data.
Results
Analysis to date of eight FGDs and IDIs indicates a dis-
connect between the information given to trial partici-
pants in the recruitment and consent process and their
understanding of the trial and its aims, with a few parti-
cipants stating they did not realise they were part of a
research study. This reflects, and may be attributable to
trial participants’ frequent conflation of the clinical
encounter - testing for malaria - with the research
encounter - the recruitment process - and an inability
to distinguish between these as separate events. When
describing recruitment, many participants framed their
narrative around clinical events such as the malaria test
and seeking treatment, the latter being considered the
most important reason for joining the study. The clini-
cal context in which participants were screened and
recruited appeared to influence their ability to interpret
information about the trial and expectations for what
may happen to them, raising questions about the nature
of ‘informed consent’ in the recruitment process.
Participants reported overwhelmingly positive experi-
ences of participating in the trial, largely based around
their access to numerous tests and free treatment, as
well as reimbursement for transport and telephone
costs. Being part of the trial was frequently conceptua-
lised as receiving a ‘service’, valued chiefly for enabling
participants to be observed and to know their health
status. The perceived value of this ‘service’ was reflected
in many participants’ reports of encouraging friends and
family to attend for malaria testing, in order to access
the service associated with the trial. Although this indi-
cates again some confusion between clinical and
research activities, it appeared that the ‘enactment’ of
the trial – giving and receiving the service – offered the
social space in which participants were likely to raise
any concerns about aspects of the trial. Such concerns
included questioning the ‘true’ aim of the study, and
f e a r so v e rb l o o dt a k i n g .T h i ss u g g e s t st h a ti ti sw i t h i na
relationship of interaction with trial staff and activities
that comprehension about the meaning and value of
participation can begin to emerge, thus highlighting the
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process.
Conclusions
The findings from this study raise questions about how
information is presented and used in the recruitment
and consenting process for a trial, particularly one
located within an existing clinical context. Recruitment
strategies should take into consideration when, where
and how information will be conveyed to participants,
and explore likely expectations of these contexts which
may shape how and if information is interpreted and
utilised by potential participants. The findings also indi-
cate that the meaning participants place on participa-
tion, its risks and benefits, develops largely through
enactment of the relationship with trial staff and activ-
ities, rather than through the consent process. To
ensure better informed consent, researchers could seek
to activate this relationship earlier on in the trial pro-
cess, for example through meaningful community
engagement activities prior to recruitment.
This study has also underscored the value participants
in this low-resource setting place on engaging with a
‘service’ of health care provision, wherein they perceive
their health status and needs to be the focus of trial
activities. This service is an influential motivator for
continuing to engage with a trial, beyond more material
compensations such as money for transport. These find-
ings also suggest the potential for word-of-mouth strate-
gies to aid informed recruitment in contexts where the
perceived benefits of participation are highly valued
amongst the local community.
Recruitment and continued participation in trials
involve logistical and ethical challenges. Understanding
values and concerns of participants can pose practical
solutions.
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